Safety of recombinant activated factor VII: a comprehensive review of controlled data from randomized clinical trials
Publication
, Journal Article
Levi, M; Levy, JH; Andersen, HF; Truloff, D
Published in: The New England journal of medicine
2010
Duke Scholars
Published In
The New England journal of medicine
ISSN
1533-4406
Publication Date
2010
Volume
363
Start / End Page
1791 / 1800
Publisher
Massachusetts Medical Society
Related Subject Headings
- General & Internal Medicine
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Levi, M., Levy, J. H., Andersen, H. F., & Truloff, D. (2010). Safety of recombinant activated factor VII: a comprehensive review of controlled data from randomized clinical trials. The New England Journal of Medicine, 363, 1791–1800.
Levi, M., J. H. Levy, H. F. Andersen, and D. Truloff. “Safety of recombinant activated factor VII: a comprehensive review of controlled data from randomized clinical trials.” The New England Journal of Medicine 363 (2010): 1791–1800.
Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII: a comprehensive review of controlled data from randomized clinical trials. The New England journal of medicine. 2010;363:1791–800.
Levi, M., et al. “Safety of recombinant activated factor VII: a comprehensive review of controlled data from randomized clinical trials.” The New England Journal of Medicine, vol. 363, Massachusetts Medical Society, 2010, pp. 1791–800.
Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII: a comprehensive review of controlled data from randomized clinical trials. The New England journal of medicine. Massachusetts Medical Society; 2010;363:1791–1800.
Published In
The New England journal of medicine
ISSN
1533-4406
Publication Date
2010
Volume
363
Start / End Page
1791 / 1800
Publisher
Massachusetts Medical Society
Related Subject Headings
- General & Internal Medicine
- 11 Medical and Health Sciences